PEOPLE: DSM appoints new Executive Vice President Corporate Strategy & Acquisitions
Royal DSM, the global Life Sciences and Materials Sciences company has appointed Philip Eykerman, (1968), currently Partner at McKinsey & Company, Brussels office, as the new Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM.
Philip will succeed Hein Schreuder, currently EVP Corporate Strategy & Acquisitions, who after a very successful career of 20 years at DSM, will retire from the company on December 31, 2011. Hein has played a key role in the transformation of DSM as well as in the acquisitions and divestments of the company during the last 15 years.
Philip, a Belgian national, joined McKinsey & Company in 1997 and is the leader of McKinsey's Chemicals Practice in the Benelux and France. He has been heavily involved in a number of significant strategy development, transformation and M & A projects in the broader chemicals industry.
With his track record of strategy development and M & A strategy and integration, Philip is well positioned to lead DSM's corporate strategy and acquisition department and drive the development of DSM's strategic growth agenda.
To comment, login here
Or register to be able to comment.